A detailed history of Gen Wealth Partners Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Gen Wealth Partners Inc holds 5,724 shares of NVO stock, worth $691,230. This represents 0.39% of its overall portfolio holdings.

Number of Shares
5,724
Previous 4,624 23.79%
Holding current value
$691,230
Previous $594 Million 37.61%
% of portfolio
0.39%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $134,981 - $161,601
1,100 Added 23.79%
5,724 $817 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $472,156 - $628,494
4,624 New
4,624 $594 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gen Wealth Partners Inc Portfolio

Follow Gen Wealth Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gen Wealth Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gen Wealth Partners Inc with notifications on news.